# Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery

> **NCT02716285** · PHASE3 · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 190 (actual)

## Conditions studied

- Irritable Bowel Syndrome
- Abdominal Pain
- Colonic Diseases, Functional

## Interventions

- **DRUG:** Ileocolonic release peppermint oil
- **DRUG:** Placebo
- **DRUG:** Small intestinal release peppermint oil

## Key facts

- **NCT ID:** NCT02716285
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-17
- **Primary completion:** 2018-05-01
- **Final completion:** 2018-10-01
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2018-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02716285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02716285, "Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02716285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*